New drug trial aims to tame debilitating autoimmune disease
NCT ID NCT05349214
Summary
This large, late-stage study is testing whether a new drug called ianalumab can help control the disease and reduce symptoms for people with active Sjogren's syndrome. About 500 participants will receive injections of either the drug or a placebo for nearly a year to see if it safely lowers disease activity and improves dryness, pain, and fatigue. The goal is to see if this treatment can provide better long-term management of this chronic autoimmune condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Medical Research
La Palma, California, 90623, United States
-
Advanced Rheumatology of Houston
Spring, Texas, 77382, United States
-
Arthritis Northwest PLLC
Spokane, Washington, 99204, United States
-
Arthritis Osteoporosis Assoc of NM
Las Cruces, New Mexico, 88011, United States
-
Arthritis and Osteoporosis
Charlotte, North Carolina, 28207, United States
-
Augusta University Georgia
Augusta, Georgia, 30912, United States
-
Bay Area Arthritis And Osteoporosis
Brandon, Florida, 33511, United States
-
Clin Invest Specialists Inc
Orland Park, Illinois, 60467, United States
-
Clinic of Robert Hozman
Skokie, Illinois, 60176, United States
-
Clinical Investigation Specialists, Inc.
Wauconda, Illinois, 60084, United States
-
First Outpatient Research Unit
San Antonio, Texas, 78229, United States
-
GNP Research
Cooper City, Florida, 33024, United States
-
North Georgia Rheumatology Group
Lawrenceville, Georgia, 30046, United States
-
Novartis Investigative Site
CABA, Buenos Aires, C1405BCH, Argentina
-
Novartis Investigative Site
Quilmes, Buenos Aires, 1878, Argentina
-
Novartis Investigative Site
San Miguel Tucuman, Tucumán Province, T4000DPK, Argentina
-
Novartis Investigative Site
Buenos Aires, 1646, Argentina
-
Novartis Investigative Site
Buenos Aires, C1055AAF, Argentina
-
Novartis Investigative Site
Buenos Aires, C1428DQG, Argentina
-
Novartis Investigative Site
Maroochydore, Queensland, 4558, Australia
-
Novartis Investigative Site
Woodville South, South Australia, 5011, Australia
-
Novartis Investigative Site
Hobart, Tasmania, 7000, Australia
-
Novartis Investigative Site
Salvador, Estado de Bahia, 40150 150, Brazil
-
Novartis Investigative Site
Curitiba, Paraná, 80030-110, Brazil
-
Novartis Investigative Site
São Paulo, São Paulo, 04266 010, Brazil
-
Novartis Investigative Site
Burgas, 8000, Bulgaria
-
Novartis Investigative Site
Plovdiv, 4002, Bulgaria
-
Novartis Investigative Site
Sofia, 1606, Bulgaria
-
Novartis Investigative Site
Vancouver, British Columbia, V5Z 1L7, Canada
-
Novartis Investigative Site
Sydney, Nova Scotia, B1P 1P3, Canada
-
Novartis Investigative Site
Toronto, Ontario, M5T 2S8, Canada
-
Novartis Investigative Site
Rimouski, Quebec, G5L 5T1, Canada
-
Novartis Investigative Site
Sherbrooke, Quebec, J1G 2E8, Canada
-
Novartis Investigative Site
Trois-Rivières, Quebec, G9A 3Y2, Canada
-
Novartis Investigative Site
Concepción, Bio Bio, 4070280, Chile
-
Novartis Investigative Site
Valdivia, Los Ríos Region, 5110683, Chile
-
Novartis Investigative Site
Santiago, RM, 7500588, Chile
-
Novartis Investigative Site
Hefei, Anhui, 230001, China
-
Novartis Investigative Site
Chongqing, Chongqing Municipality, 400010, China
-
Novartis Investigative Site
Nanjing, Jiangsu, 210008, China
-
Novartis Investigative Site
Nanchang, Jiangxi, 330006, China
-
Novartis Investigative Site
Pingxiang, Jiangxi, 337000, China
-
Novartis Investigative Site
Changchun, Jilin, 130021, China
-
Novartis Investigative Site
Taiyuan, Shanxi, 030001, China
-
Novartis Investigative Site
Chengdu, Sichuan, 610041, China
-
Novartis Investigative Site
Yinchuan, The Ningxia Hui Autonomous Reg, 750000, China
-
Novartis Investigative Site
Ürümqi, Xinjiang, 830001, China
-
Novartis Investigative Site
Hangzhou, Zhejiang, 310006, China
-
Novartis Investigative Site
Beijing, 100029, China
-
Novartis Investigative Site
Beijing, 100730, China
-
Novartis Investigative Site
Shanghai, 200011, China
-
Novartis Investigative Site
Shanghai, 200040, China
-
Novartis Investigative Site
Tianjin, 300052, China
-
Novartis Investigative Site
Xinxiang, 453099, China
-
Novartis Investigative Site
Medellín, Antioquia, 050001, Colombia
-
Novartis Investigative Site
Barranquilla, Atlántico, 080002, Colombia
-
Novartis Investigative Site
Bogota, Cundinamarca, 110221, Colombia
-
Novartis Investigative Site
Bucaramanga, Santander Department, 680003, Colombia
-
Novartis Investigative Site
Angers, 49933, France
-
Novartis Investigative Site
Brest, 29200, France
-
Novartis Investigative Site
Le Kremlin-Bicêtre, 94275, France
-
Novartis Investigative Site
Le Mans, 72000, France
-
Novartis Investigative Site
Strasbourg, 67000, France
-
Novartis Investigative Site
Cologne, North Rhine-Westphalia, 50937, Germany
-
Novartis Investigative Site
Dresden, Saxony, 01307, Germany
-
Novartis Investigative Site
Berlin, 13125, Germany
-
Novartis Investigative Site
Hanover, 30625, Germany
-
Novartis Investigative Site
Herne, 44649, Germany
-
Novartis Investigative Site
Athens, 115 21, Greece
-
Novartis Investigative Site
Athens, 115 27, Greece
-
Novartis Investigative Site
Székesfehérvár, Fejér, 8000, Hungary
-
Novartis Investigative Site
Debrecen, Hajdu Bihar Megye, 4032, Hungary
-
Novartis Investigative Site
Eger, 3300, Hungary
-
Novartis Investigative Site
Gyula, 5700, Hungary
-
Novartis Investigative Site
Szeged, 6725, Hungary
-
Novartis Investigative Site
Ahmedabad, Gujarat, 380013, India
-
Novartis Investigative Site
Ahmedabad, Gujarat, 380015, India
-
Novartis Investigative Site
Bangalore, Karnataka, 560 002, India
-
Novartis Investigative Site
Pune, Maharashtra, 411001, India
-
Novartis Investigative Site
New Delhi, 110029, India
-
Novartis Investigative Site
Kfar Saba, 4428164, Israel
-
Novartis Investigative Site
Ramat Gan, 5265601, Israel
-
Novartis Investigative Site
Ancona, AN, 60126, Italy
-
Novartis Investigative Site
Milan, MI, 20100, Italy
-
Novartis Investigative Site
Salerno, SA, 84131, Italy
-
Novartis Investigative Site
Udine, UD, 33100, Italy
-
Novartis Investigative Site
Naples, 80131, Italy
-
Novartis Investigative Site
Nagoya, Aichi-ken, 455-8530, Japan
-
Novartis Investigative Site
Nagoya, Aichi-ken, 4578510, Japan
-
Novartis Investigative Site
Nagoya, Aichi-ken, 4578511, Japan
-
Novartis Investigative Site
Kitakyushu, Fukuoka, 8078556, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 0608543, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 0608648, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 2458575, Japan
-
Novartis Investigative Site
Kuwana, Mie-ken, 511-0061, Japan
-
Novartis Investigative Site
Sasebo, Nagasaki, 857-1195, Japan
-
Novartis Investigative Site
Kurashiki, Okayama-ken, 7100824, Japan
-
Novartis Investigative Site
Bunkyo Ku, Tokyo, 1138431, Japan
-
Novartis Investigative Site
Chuo Ku, Tokyo, 1048560, Japan
-
Novartis Investigative Site
Itabashi-ku, Tokyo, 1738610, Japan
-
Novartis Investigative Site
Meguro-ku, Tokyo, 152-8902, Japan
-
Novartis Investigative Site
Shinjuku-ku, Tokyo, 1608582, Japan
-
Novartis Investigative Site
Culiacán, Sinaloa, 80000, Mexico
-
Novartis Investigative Site
Mérida, Yucatán, 97070, Mexico
-
Novartis Investigative Site
México, 07029, Mexico
-
Novartis Investigative Site
Poznan, Greater Poland Voivodeship, 61-397, Poland
-
Novartis Investigative Site
Krakow, Lesser Poland Voivodeship, 30-727, Poland
-
Novartis Investigative Site
Wroclaw, Lower Silesian Voivodeship, 52-416, Poland
-
Novartis Investigative Site
Warsaw, 00-874, Poland
-
Novartis Investigative Site
Wroclaw, 50367, Poland
-
Novartis Investigative Site
Cluj-Napoca, Cluj, 400006, Romania
-
Novartis Investigative Site
Brasov, 500283, Romania
-
Novartis Investigative Site
Bucharest, 010825, Romania
-
Novartis Investigative Site
Bucharest, 011172, Romania
-
Novartis Investigative Site
Bratislava, 811 08, Slovakia
-
Novartis Investigative Site
Košice, 040 11, Slovakia
-
Novartis Investigative Site
Partizánske, 958 01, Slovakia
-
Novartis Investigative Site
Zvolen, 960 01, Slovakia
-
Novartis Investigative Site
Panorama, Western Cape, 7500, South Africa
-
Novartis Investigative Site
Stellenbosch, Western Cape, 7600, South Africa
-
Novartis Investigative Site
Santander, Cantabria, 39008, Spain
-
Novartis Investigative Site
Vigo, Pontevedra, 36214, Spain
-
Novartis Investigative Site
Barcelona, 08041, Spain
-
Novartis Investigative Site
Córdoba, 14004, Spain
-
Novartis Investigative Site
Madrid, 28009, Spain
-
Novartis Investigative Site
Valencia, 46026, Spain
-
Novartis Investigative Site
Stockholm, SE, 113 65, Sweden
-
Novartis Investigative Site
Kaohsiung City, 81346, Taiwan
-
Novartis Investigative Site
Kaohsiung City, 83301, Taiwan
-
Novartis Investigative Site
Taichung, 40447, Taiwan
-
Novartis Investigative Site
Taichung, 407219, Taiwan
-
Novartis Investigative Site
Doncaster, DN2 5LT, United Kingdom
-
Novartis Investigative Site
Leeds, LS1 3EX, United Kingdom
-
Novartis Investigative Site
Liverpool, L9 7AL, United Kingdom
-
Novartis Investigative Site
Newcastle upon Tyne, NE1 4LP, United Kingdom
-
Novartis Investigative Site
Swindon, SN3 6BB, United Kingdom
-
On Site Clinical Solutions Llc
Charlotte, North Carolina, 28202, United States
-
Prolato Clinical Research Center
Houston, Texas, 77054, United States
-
Providence Medical Foundation
Fullerton, California, 92835, United States
-
RAO Research LLC
Oklahoma City, Oklahoma, 73116, United States
-
Ramesh C Gupta MD Memphis TN
Memphis, Tennessee, 38119, United States
-
Sarasota Arthritis Res Ctr
Sarasota, Florida, 34239, United States
-
St Lawrence Health System
Potsdam, New York, 13676, United States
-
Tufts School of Dental Medicine
Boston, Massachusetts, 02111, United States
-
University of Kansas Hospital
Kansas City, Kansas, 66160, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States
Conditions
Explore the condition pages connected to this study.